EUVIMEDDescobrir EUVIMED
Vergleichsstudie

The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin‐A in chronic hemodialysis patients

Suleyman Karakose iD, Zeynep Bal, Siren Sezer

Seminars in Dialysis · 2024

DOI: 10.1111/sdi.13167 ↗

At a glance

Vergleichsstudie in Seminars in Dialysis, 2024. Written by Suleyman Karakose and 2 co-authors. Institution: Nephrology Department, University of Health Sciences, Konya City Hospital, Konya, Turkey. Major MEDLINE topics: Calcitriol, Ergocalciferols, Vascular Calcification. Cited 2 times so far (Crossref); 31 references. Funded by: Scientific Research Project of Baskent University Faculty of Medicine.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Introduction

Vascular calcification is an intervenable factor in the pathophysiology of cardiovascular disease. Treatment‐related factors might worsen the arterial stiffness in chronic hemodialysis patients. The aim of the study is to compare the effects of 1‐year treatment with paricalcitol or calcitriol on pulse wave velocity (PWV), which is an indicator of arterial stiffness and osteocalcin and fetuin‐A levels.

Methods

Seventy‐six hemodialysis patients who had similar PWV1 at the beginning were evaluated after a 1‐year treatment of paricalcitol or calcitriol. PWV2, serum osteocalcin, and fetuin‐A levels were measured at the end of the study.

Results

At the end of the study, PWV2 of paricalcitol group was statistically lower than the calcitriol group. Osteocalcin levels were statistically lower and fetuin‐A levels were statistically higher in the paricalcitol group than the calcitriol group at the end of the study. The number of patients with PWV2 > 7 m/s and using paricalcitol was 16 (39%) but 25 (41%) patients were using calcitriol; the differences were statistically significant.

Conclusions

The long‐term benefits of paricalcitol were superior to the benefits of calcitriol. Paricalcitol has protective effects from vascular calcification in chronic hemodialysis patients.

Subjects

MeSH terms (MEDLINE)

CalcitriolErgocalciferolsVascular CalcificationHumansalpha-2-HS-GlycoproteinOsteocalcinParathyroid HormonePulse Wave AnalysisRenal Dialysis

Substances

alpha-2-HS-GlycoproteinCalcitriolErgocalciferolsOsteocalcinParathyroid Hormoneparicalcitol

Authors and institutions

  • Nephrology Department, University of Health Sciences, Konya City Hospital, Konya, Turkey.
  • Nephrology Department, Baskent University Faculty of Medicine, Ankara, Turkey.

ORCID profiles: Suleyman Karakose

Funding

  • Scientific Research Project of Baskent University Faculty of Medicine

Cite

APA

Karakose, S., Bal, Z., & Sezer, S. (2024). The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin‐A in chronic hemodialysis patients. Seminars in Dialysis. https://doi.org/10.1111/sdi.13167

Vancouver

Karakose S, Bal Z, Sezer S. The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin‐A in chronic hemodialysis patients. Seminars in Dialysis. 2024. doi:10.1111/sdi.13167

BibTeX
@article{Karakose2024,
  author = {Karakose, Suleyman and Bal, Zeynep and Sezer, Siren},
  title = {The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin‐A in chronic hemodialysis patients},
  journal = {Seminars in Dialysis},
  year = {2024},
  doi = {10.1111/sdi.13167}
}
Start for free →